Ketamine, a racemic mixture consisting of (S)-and (R)-ketamine, has been in clinical use
since 1970. Although best characterized for its dissociative anesthetic properties, ketamine …

This paper summarises data for the prevalence, correlates, and probable adverse health
consequences of problem use of amphetamines, cannabis, cocaine, and opioids. We …

Issues. The major physical and psychological health effects of methamphetamine use, and
the factors associated with such harms. Approach. Comprehensive review. Key Findings …

Significant public health problems associated with methamphetamine (MA) production and
use in the United States have emerged over the past 25 years; however, there has been …

Ketamine is a phencyclidine derivative and a non-competitive antagonist of N-methyl-D-
aspartate (NMDA) receptor for which glutamate is the full agonist. It produces a functional …

Background Methamphetamine use and stroke are significant public health problems.
Strokes among people aged below 45 years are much less common than in older age …

Aims To examine the literature pertaining to the cardiovascular effects of methamphetamine
and discuss the implications for methamphetamine users. Methods Relevant literature was …

Psychostimulant users are typically young adults. We have conducted a narrative review of
neuropsychiatric harms associated with the psychostimulants methamphetamine …

Crystal meth is a form of the stimulant drug methamphetamine that, when smoked, can
rapidly achieve high concentrations in the brain. Methamphetamine causes the release of …

Aims To (1) assess trends in the number and mortality rates of methamphetamine‐related
death in Australia, 2009–15;(2) assess the characteristics and the cause, manner and …